Quantcast
Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to Dividend.com. Please help us personalize your experience.

Select the one that best describes you
ALERT

Packaging Materials Best Dividend Stock Makes Boring Profitable

Dividend logo

Gilead Sciences, Inc. (GILD ) is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines. The company’s primary areas of focus are immunodeficiency virus (HIV), liver diseases, such as chronic hepatitis C virus (HCV) and chronic hepatitis B virus (HBV), oncology and inflammation, and serious cardiovascular and respiratory conditions. The company has two high-profile treatments: Harvoni and Sovaldi. These two drugs accounted for nearly 60% of the company’s revenue in both quarters of 2015.

Additionally, Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands approximately 75% of the U.S. treatment market and more than 50% worldwide.

Gilead Sciences recently started paying a quarterly dividend of $0.43 per share. Its first payout was on 6/29/2015. It’s going Ex-Dividend again on 9/14/2015. Its annual payout comes to $1.72, yielding 1.50% on its current price of $114.

To read the Full Story, Go Premium or Log In

Popular Articles

Premium Utilitiesstock
News

Double-Digit Dividend Growth for West Coast Utilities Best Dividend Stock

For utilities relying on fossil fuel and nuclear energy, the last few years haven’t exactly been...

Premium Shutterstock 651131272
News

Honeywell Continues to Improve in Rank on Most Watched Stocks List

Last week, we reported that Honeywell moved up one spot on the Most Watched Stocks List. This...

Premium Shutterstock 190440584
News

Invesco Says: Start to Samba

Boy, what a difference a few years make. For Brazil, it’s the turnaround it so badly needed.

The...